SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-086848
Filing Date
2023-11-14
Accepted
2023-11-14 15:47:39
Documents
15
Period of Report
2023-11-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea188243-8k_redwoods.htm   iXBRL 8-K 39404
2 CERTIFICATE OF AMENDMENT, DATED NOVEMBER 13, 2023, TO AMENDED AND RESTATED CERTI ea188243ex3-1_redwoods.htm EX-3.1 9135
3 AMENDMENT NO. 2 TO THE INVESTMENT MANAGEMENT TRUST AGREEMENT, DATED NOVEMBER 13 ea188243ex10-1_redwoods.htm EX-10.1 17649
  Complete submission text file 0001213900-23-086848.txt   304960

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rwod-20231113.xsd EX-101.SCH 3685
5 XBRL DEFINITION FILE rwod-20231113_def.xml EX-101.DEF 27225
6 XBRL LABEL FILE rwod-20231113_lab.xml EX-101.LAB 37383
7 XBRL PRESENTATION FILE rwod-20231113_pre.xml EX-101.PRE 25841
9 EXTRACTED XBRL INSTANCE DOCUMENT ea188243-8k_redwoods_htm.xml XML 6752
Mailing Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010
Business Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010 646-916-5315
Redwoods Acquisition Corp. (Filer) CIK: 0001907223 (see all company filings)

IRS No.: 862727441 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41340 | Film No.: 231405343
SIC: 2836 Biological Products, (No Diagnostic Substances)